Adani Group Shares Rally Recouping Nearly 150 Billion in Lost Market Value PostHindenburg Uber Explores Full Takeover of Delivery Hero What It Could Mean for the Food Delivery Landscape General Motors Unveils AllElectric Cadillac Vistiq with 300Mile Range Matador Resources Bolsters Delaware Basin Presence with 11 Billion Lease Acquisition Ethical Hacker and CBSE Clash Over Board Exam Portal Data Security Flaw WW Grainger Stock Analyzing Wall Streets Mixed Sentiment DEI Q1 2026 Earnings EPS Surprise of 604 Highlights Operational Discipline BMEA Q1 2026 Earnings Narrower Loss Beats Expectations as Clinical Progress Continues YORW Q1 2026 Earnings EPS Surpasses Estimates as Utility Delivers Steady Performance TOWN Q1 2026 Earnings EPS Misses Estimates by Nearly 5 Stock Edges Lower ClearSign Technologies CLIR Q1 2026 Earnings WiderthanExpected Loss Reflects Continued Development Stage RB Global Inc Q1 2026 Earnings EPS Slightly Beats Estimates Shares Edge Higher Acumen Pharmaceuticals ABOS Surges 62 Above Support as Biotech Momentum Builds Ensysce Biosciences ENSC Drops 3 as Stock Nears Support at 028 Magnachip Semiconductor MX Slides 417 as Broader Tech Selloff Weighs on Sentiment Genelux Corporation GNLX Edges Higher in LowVolatility Trading Holding Above Key Support Jazz Pharmaceuticals JAZZ Holds Flat Near Key Resistance Amid LowVolume Consolidation SP 500 Edges Higher as Healthcare and Technology Lead Communication Services Lags FRMI Q1 2026 Earnings Massive EPS Miss Shocks Expectations Shares Surprisingly Rise Mesa Royalty Trust MTR Advances 131 as Price Approaches Key Resistance at 405 InMode INMD Rebounds 163 as Shares Find Support Near 1334 KTech Solutions KMRK Holds Steady at 202 Amid Key Technical Levels Cadrenal Therapeutics CVKD Holds Steady at 519 as Shares Test Key Technical Levels Medline Inc MDLN Edges Lower as Support Levels Remain in Focus Smucker SJM Advances 13 as Defensive Appeal Shines Amid Market Uncertainty Taysha Gene Therapies TSHA Holds Steady Near Support as Biotech Sentiment Improves Phio Pharmaceuticals PHIO Holds Steady at 109 as Stock Consolidates Between Key Levels